These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1738123)
1. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat. MacNaughton WK; Catto-Smith AG; Gall DG J Pharmacol Exp Ther; 1992 Feb; 260(2):773-9. PubMed ID: 1738123 [TBL] [Abstract][Full Text] [Related]
2. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility. Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979 [TBL] [Abstract][Full Text] [Related]
4. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of platelet-activating factor-induced electrolyte transport in the rat jejunum. MacNaughton WK; Gall DG Eur J Pharmacol; 1991 Jul; 200(1):17-23. PubMed ID: 1769369 [TBL] [Abstract][Full Text] [Related]
6. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. de Lima WT; Sirois P; Jancar S Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472 [TBL] [Abstract][Full Text] [Related]
7. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W; McNicholl IK; Choy PC; Man RY Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473 [TBL] [Abstract][Full Text] [Related]
9. The role of lipid mediators in asthma (current views and perspectives). König W; Schönfeld W; Knöller J; Köller M Allergol Immunopathol (Madr); 1988; 16(5):289-98. PubMed ID: 3147587 [TBL] [Abstract][Full Text] [Related]
10. SK&F 104353: selective antagonism of peptidoleukotrine-induced changes in electrolyte transport by rat ileal mucosa in vitro. Elton E; Chiossone DC; McCafferty GP; Ryan FM; Smith PL J Pharmacol Exp Ther; 1989 Nov; 251(2):484-9. PubMed ID: 2553922 [TBL] [Abstract][Full Text] [Related]
11. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery. Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567 [TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors. Dubois C; Bissonnette E; Rola-Pleszczynski M J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780 [TBL] [Abstract][Full Text] [Related]
13. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs. Cheng JB; Pillar JS; Conklyn MJ; Breslow R; Shirley JT; Showell HJ J Pharmacol Exp Ther; 1990 Nov; 255(2):664-71. PubMed ID: 2243346 [TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor contributes to immune cell and oxidant-mediated intestinal secretion. Hinterleitner TA; Valentich JD; Cha JH; Will P; Welton A; Powell DW J Pharmacol Exp Ther; 1997 Jun; 281(3):1264-71. PubMed ID: 9190862 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart. Stahl GL; Lefer AM Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906 [TBL] [Abstract][Full Text] [Related]
16. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. Jakubowski A; Olszanecki R; Chlopicki S J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362 [TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A; Serhan CN; Brady HR J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
19. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. Diven WF; Burckart GJ; Alper CM; Jaffe R; Evans RW; Doyle WJ Ann Otol Rhinol Laryngol; 1998 Mar; 107(3):199-206. PubMed ID: 9525240 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Landgraf RG; Nossi DF; Sirois P; Jancar S Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]